Chargement en cours...
Immunization for meningococcal serogroup B: What does the practitioner need to know?
Most invasive meningococcal disease in Canada is now caused by serogroup B organisms. A vaccine directed against this serogroup (4CMenB) is newly licensed in Canada. A decision will need to be made by all provinces and territories regarding whether a routine infant immunization program is warranted....
Enregistré dans:
| Auteur principal: | |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Pulsus Group Inc
2014
|
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3941677/ https://ncbi.nlm.nih.gov/pubmed/24596484 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|